Customer Support: +353 (0)1 857 6730

Corporate Website About Us
  • There are no items in your cart
Please enter a keyword to search
Advanced search
Home
AS
AS ISO 25539.1-2003

AS ISO 25539.1-2003

Withdrawn

Withdrawn

A Withdrawn Standard is one, which is removed from sale, and its unique number can no longer be used. The Standard can be withdrawn and not replaced, or it can be withdrawn and replaced by a Standard with a different number.

Cardiovascular implants - Endovascular devices - Endovascular prostheses

Available format(s)

Hardcopy , PDF 1 User , PDF 3 Users , PDF 5 Users , PDF 9 Users

Withdrawn date

06-06-2019

Language(s)

English

Published date

01-01-2003

Publisher

Standards Australia

Preview

1 - AS ISO 25539.1-2003 CARDIOVASCULAR IMPLANTS-ENDOVASCULAR DEVICES - ENDOVASCULAR PROSTHESES
4 - PREFACE
6 - CONTENTS
7 - INTRODUCTION
9 - 1 Scope
9 - 2 Normative references
10 - 3 Terms and definitions
10 - 3.1 attachment system
10 - 3.2 delivery system
10 - 3.3 determine
10 - 3.4 endoleak
10 - 3.5 endovascular prosthesis endovascular graft endovascular implant
11 - 3.6 endovascular system
11 - 3.7 evaluate
11 - 3.8 graft material
11 - 3.9 reportable clinical events
11 - 4 Intended performance
11 - 5 Design attributes
11 - 5.1 General
12 - 5.2 Delivery system
12 - 5.3 Implant
12 - 6 Materials
13 - 7 Design evaluation
13 - 7.1 General
13 - 7.2 Delivery (and/or endovascular) system
13 - 7.2.1 Ability to access
15 - 7.2.2 Ability to deploy
17 - 7.2.3 Ability to withdraw
18 - 7.2.4 Biocompatibility
18 - 7.2.5 Haemostasis
19 - 7.3 Implant
19 - 7.3.1 Ability to accurately deploy
20 - 7.3.2 Fixation effectiveness
21 - 7.3.3 Implant integrity
23 - 7.3.4 Permeability
23 - 7.3.5 Modularity
24 - 7.3.6 Sizing
25 - 7.3.7 Patency
26 - 7.3.8 Magnetic resonance imaging (MRI) compatibility
27 - 7.4 Preclinical in vivo evaluation
27 - 7.4.1 Purpose
27 - 7.4.2 Specific aims
27 - 7.4.3 Protocol
27 - 7.4.4 Data acquisition
29 - 7.4.5 Test report and additional information
30 - 7.5 Clinical evaluation
30 - 7.5.1 Purpose
30 - 7.5.2 Specific aims
30 - 7.5.3 Protocol
31 - 7.5.4 Data acquisition
32 - 7.5.5 Final report
33 - 8 Manufacturing
33 - 9 Sterilization
33 - 9.1 Products supplied sterile
34 - 9.2 Products supplied non-sterile
34 - 9.3 Sterilization residuals
34 - 10 Packaging
34 - 10.1 Protection from damage in storage and transport
34 - 10.1.1 General
34 - 10.1.2 Unit container
34 - 10.1.3 Outer container
34 - 10.1.4 Shipping container
34 - 10.1.5 Maintenance of sterility in transit
35 - 10.2 Marking
35 - 10.2.1 Container label
35 - 10.2.2 Record label
35 - 10.3 Information supplied by the manufacturer
35 - 10.3.1 General
36 - 10.3.2 Information and instructions for use
37 - Annex A - Attributes of endovascular devices - Technical and clinical considerations
44 - Annex B - Bench and analytical tests
47 - Annex C - Definitions of reportable clinical events
50 - Bibliography

Specifies requirements for endovascular prostheses, based upon current medical knowledge. With regard to safety, it gives requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization packaging and information supplied by the manufacturer. It should be considered as a supplement to AS ISO 14630, which specifies general requirements for the performance of non-active surgical implants. It is applicable to endovascular prostheses used to treat arterial aneurysms, arterial stenoses, or other appropriate vascular abnormalities.

Committee
HE-012
DocumentType
Standard
ISBN
0 7337 5341 8
Pages
42
ProductNote
Withdrawn 06-06-2019.
PublisherName
Standards Australia
Status
Withdrawn
Supersedes

1.1 This part of ISO 25539 specifies requirements for endovascular prostheses, based upon currentmedical knowledge. With regard to safety, it gives requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization packaging and information supplied by the manufacturer. It should be considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.1.2 This part of ISO 25539 is applicable to endovascular prostheses used to treat arterial aneurysms, arterial stenoses, or other appropriate vascular abnormalities.1.3 This part of ISO 25539 is applicable to delivery systems if they comprise an integral component of the deployment of the endovascular prostheses.1.4 This part of ISO 25539 is not applicable to vascular occluders, with the exception of contra-lateral iliac occluders when used as an integral part of an aorto-uni-iliac device. See ISO 14630 for excluded products.1.5 This part of ISO 25539 is not applicable to procedures and devices used prior to the introduction of the endovascular system (defined in 3.6), such as balloon angioplasty devices.

Standards Relationship
ISO 25539-1:2003 Identical

First published as AS ISO 25539.1-2003.

View more information
€126.62
Excluding VAT
EUR
CAD
CHF
CNY
DKK
EUR
GBP
HKD
IDR
INR
JPY
KRW
MXN
NOK
NZD
SEK
SGD
USD
ZAR
Hardcopy - English
PDF 1 User - English
PDF 3 Users - English
PDF 5 Users - English
PDF 9 Users - English
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20

Access your standards online with a subscription

Features

  • Simple online access to standards, technical information and regulations.

  • Critical updates of standards and customisable alerts and notifications.

  • Multi-user online standards collection: secure, flexible and cost effective.

Get in touch with us